Xiuning Le, MD, PhD | Authors


Using and Sequencing EGFR Exon 20-Targeted Therapies for NSCLC

April 27, 2022

Xiuning Le, MD, PhD, discusses counseling patients on the use of amivantamab-vmjw and mobocertinib and the sequencing of these drugs for patients with non–small cell lung cancer and an EGFR exon 20 insertion.